Cargando…
Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
O-glycosylation is a common protein modification. Aberrant O-glycosylation is associated with many cancers. GALNT1 is a GalNAc-transferase that initiates protein O-glycosylation. We found that GALNT1 is frequently up-regulated in hepatocellular carcinoma (HCC) and is associated with poor patient sur...
Autores principales: | Huang, Miao-Juei, Hu, Rey-Heng, Chou, Chih-Hsing, Hsu, Chia-Lang, Liu, Ya-Wen, Huang, John, Hung, Ji-Shiang, Lai, I-Rue, Juan, Hsueh-Fen, Yu, Sung-Liang, Wu, Yao-Ming, Huang, Min-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467392/ https://www.ncbi.nlm.nih.gov/pubmed/25730904 |
Ejemplares similares
-
Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
por: Liu, Shin-Yun, et al.
Publicado: (2016) -
GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity
por: Lin, Tzu-Chi, et al.
Publicado: (2017) -
GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma
por: Ho, Wan-Ling, et al.
Publicado: (2014) -
Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown()
por: Tarhan, Yunus Emre, et al.
Publicado: (2016) -
GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL
por: Liao, Ying‐Yu, et al.
Publicado: (2022)